Dr. Jared D. Ament, MD, MPH

Dr. Ament practices at UCLA West Valley Medical Center in West Hills, California, part of University of California Health.

Dr. Ament's NPI, 1356653927, was assigned on July 12, 2010. Dr. Ament graduated from Ben Gurion University of the Negev in 2007. Dr. Ament holds California license A122608.

Dr. Ament's primary practice is UCLA West Valley Medical Center, at 7300 Medical Center Dr, West Hills, CA 91307 in Los Angeles County. The practice phone is (818) 676-4000.

Dr. Ament's primary practice is UCLA West Valley Medical Center in West Hills, California, part of University of California Health. Dmand AI also links Dr. Ament to 1 physician office, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ament practices, 2 sites in all. Vendor and product names are available with a free account.

Neurological surgery is Dr. Ament's primary specialty in the NPI Registry, under taxonomy code 207T00000X. Dr. Ament is board certified in neurological surgery by the American Board of Neurological Surgery. Dr. Ament is licensed in California.

Dmand AI lists back and neck pain treatment without fusion, craniotomy, lower back pain, neck pain and spine problems, spinal fusion and thoracic spine disorders among the conditions Dr. Ament treats.

CMS data shows 368 Medicare services from Dr. Ament across 5 procedure codes in 2024, for 225 Medicare patients. Medicare paid $64,286 for them.

CMS counts 225 Medicare patients who saw Dr. Ament in 2024. The largest group is 65 to 74, with 102 patients. 75% of them have arthritis, and 75% have high blood pressure. 24% are also on Medicaid. Their average risk score is 1.50, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ament's median patient age at 60, with 49% women.

In 2024, Dr. Ament wrote 78 Medicare Part D claims for 38 patients. 97% of them were for generic drugs. CMS names the drug for 28 of them, across 2 drugs with 11 or more claims each, at $206 in total drug cost. In 2023, CMS named 35 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Ament for performance year 2024, reported individually.

Dmand AI links 20 papers to Dr. Ament, published from 2009 to 2019. 2017 was the busiest year, with 3. The most frequent topics are Cost-Benefit Analysis, Prostheses and Implants and Cornea. Dr. Ament has published most often in Spine (Phila Pa 1976). Dr. Ament's most frequent co-authors are Kee D. Kim, MD, Bart Thaci, MD and Joshua Michael Ammerman, MD.

Dmand AI links Dr. Ament to 1 clinical trial. Conditions studied include Brain Injuries and Craniocerebral Trauma.

CMS Open Payments shows 236 general payments to Dr. Ament from 50 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 86% of the total. Vertex Pharmaceuticals Incorporated paid the most, $135,551.

Dr. Ament graduated from Ben Gurion University of the Negev in 2007. Dr. Ament is a member of AANS and CNS.

Dr. Ament is in network with 17 carriers, including Elevance, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.